|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.26 EUR | -0.31% |
|
-1.68% | +1.85% |
| Feb. 25 | European Stock Markets in the Green, CAC 40 Hits New Record Amid Earnings Deluge | |
| Feb. 25 | Legal Confusion in Brazil for Edenred |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.81 | 3.14 | 3.5 | 2.77 | 3.73 | |||||
Return on Total Capital | 11.74 | 12.59 | 13.94 | 10.24 | 12.5 | |||||
Return On Equity % | -24.44 | -34.25 | -56.28 | -52.12 | -79.1 | |||||
Return on Common Equity | -19.64 | -28.68 | -46.2 | -38.22 | -63.89 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 40.34 | 42.14 | 41.46 | 41.19 | 41.28 | |||||
SG&A Margin | - | - | - | - | - | |||||
EBITDA Margin % | 35.49 | 37.78 | 37.04 | 28 | 37.33 | |||||
EBITA Margin % | 34.5 | 36.89 | 36.37 | 25.75 | 36.8 | |||||
EBIT Margin % | 28.88 | 31.33 | 30.97 | 23.5 | 30.39 | |||||
Income From Continuing Operations Margin % | 18.69 | 21.67 | 21.45 | 13.33 | 20.89 | |||||
Net Income Margin % | 16.73 | 19.77 | 19.86 | 11.55 | 19.43 | |||||
Net Avail. For Common Margin % | 16.73 | 19.77 | 19.86 | 11.55 | 19.43 | |||||
Normalized Net Income Margin | 16.92 | 18.99 | 18.88 | 13.75 | 18.35 | |||||
Levered Free Cash Flow Margin | 27.01 | 26.81 | 39.93 | 42.54 | 18.16 | |||||
Unlevered Free Cash Flow Margin | 28.59 | 28.11 | 41.22 | 46.06 | 22.33 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.16 | 0.16 | 0.18 | 0.19 | 0.2 | |||||
Fixed Assets Turnover | 8.98 | 10.41 | 12.42 | 14.58 | 15.3 | |||||
Receivables Turnover (Average Receivables) | 0.75 | 0.82 | 0.81 | 0.85 | 0.94 | |||||
Inventory Turnover (Average Inventory) | 22.64 | 20.58 | 21.68 | 21.57 | 23.75 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.94 | 0.98 | 0.99 | 0.92 | 0.85 | |||||
Quick Ratio | 0.56 | 0.66 | 0.73 | 0.69 | 0.64 | |||||
Operating Cash Flow to Current Liabilities | 0.1 | 0.08 | 0.12 | 0.11 | 0.1 | |||||
Days Sales Outstanding (Average Receivables) | 490.74 | 445.24 | 449.02 | 430.54 | 389.43 | |||||
Days Outstanding Inventory (Average Inventory) | 16.17 | 17.73 | 16.84 | 16.92 | 15.41 | |||||
Average Days Payable Outstanding | 197.9 | 276.03 | 278.11 | 358.59 | 412.98 | |||||
Cash Conversion Cycle (Average Days) | 309.01 | 186.94 | 187.75 | 88.87 | -8.14 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | -299.03 | -407.13 | -545.02 | -785.59 | -597.9 | |||||
Total Debt / Total Capital | 150.24 | 132.56 | 122.47 | 114.59 | 120.08 | |||||
LT Debt/Equity | -266.93 | -361.68 | -510.77 | -679.26 | -485.04 | |||||
Long-Term Debt / Total Capital | 134.12 | 117.76 | 114.77 | 99.08 | 97.42 | |||||
Total Liabilities / Total Assets | 112.03 | 108.42 | 105.49 | 104.28 | 106.1 | |||||
EBIT / Interest Expense | 11.42 | 15.03 | 15.05 | 4.18 | 4.56 | |||||
EBITDA / Interest Expense | 14.89 | 19.03 | 18.78 | 5.66 | 5.85 | |||||
(EBITDA - Capex) / Interest Expense | 12 | 15.58 | 15 | 4.2 | 4.6 | |||||
Total Debt / EBITDA | 6.33 | 5.63 | 4.45 | 6.07 | 4.75 | |||||
Net Debt / EBITDA | 2.32 | 1.31 | 0.42 | 1.51 | 1.77 | |||||
Total Debt / (EBITDA - Capex) | 7.85 | 6.88 | 5.57 | 8.19 | 6.04 | |||||
Net Debt / (EBITDA - Capex) | 2.88 | 1.6 | 0.53 | 2.03 | 2.25 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -9.36 | 11.24 | 22.8 | 18.88 | 12.89 | |||||
Gross Profit, 1 Yr. Growth % | -12.9 | 16.2 | 20.84 | 18.11 | 13.13 | |||||
EBITDA, 1 Yr. Growth % | -15.83 | 18.42 | 20.4 | -5.41 | 39.34 | |||||
EBITA, 1 Yr. Growth % | -16.07 | 18.94 | 21.06 | -7.89 | 40.35 | |||||
EBIT, 1 Yr. Growth % | -18.61 | 20.68 | 21.37 | -9.8 | 46.04 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -23.12 | 28.95 | 21.57 | -26.14 | 76.95 | |||||
Net Income, 1 Yr. Growth % | -23.72 | 31.51 | 23.32 | -30.83 | 89.89 | |||||
Normalized Net Income, 1 Yr. Growth % | -20.35 | 24.87 | 22.12 | -13.45 | 50.71 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -24.81 | 22.68 | 22.69 | -30.82 | 99.01 | |||||
Accounts Receivable, 1 Yr. Growth % | -15.92 | 21.57 | 25.72 | 4.65 | -0.86 | |||||
Inventory, 1 Yr. Growth % | 34.38 | 6.98 | 28.26 | 13.56 | -7.46 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -12.43 | 5.41 | 0.64 | 1.91 | 13.12 | |||||
Total Assets, 1 Yr. Growth % | 6.1 | 9.49 | 8.24 | 18.98 | -0.22 | |||||
Tangible Book Value, 1 Yr. Growth % | -4.6 | -6.16 | -2.39 | 53.9 | 15.35 | |||||
Common Equity, 1 Yr. Growth % | 3.1 | -22.52 | -24.66 | -5.43 | 33.73 | |||||
Cash From Operations, 1 Yr. Growth % | 54.41 | -15.88 | 67.72 | 3.85 | -2.19 | |||||
Capital Expenditures, 1 Yr. Growth % | 0.97 | 9.62 | 32.46 | 25.83 | 14.21 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 71.5 | -16.69 | 82.92 | 25.68 | -51.8 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 64.98 | -16.33 | 80.06 | 31.85 | -45.26 | |||||
Dividend Per Share, 1 Yr. Growth % | 7.14 | 20 | 11.11 | 10 | 10 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 3.55 | 0.41 | 16.88 | 20.83 | 15.85 | |||||
Gross Profit, 2 Yr. CAGR % | 2.44 | 0.61 | 18.5 | 19.47 | 15.6 | |||||
EBITDA, 2 Yr. CAGR % | 1.83 | -0.17 | 19.4 | 4.02 | 19.33 | |||||
EBITA, 2 Yr. CAGR % | 1.88 | -0.09 | 20 | 0.94 | 21.9 | |||||
EBIT, 2 Yr. CAGR % | -0.12 | -0.9 | 21.03 | 4.63 | 14.77 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -3.39 | -0.43 | 25.21 | -5.24 | 14.32 | |||||
Net Income, 2 Yr. CAGR % | -3.2 | 0.16 | 27.35 | -7.64 | 14.61 | |||||
Normalized Net Income, 2 Yr. CAGR % | -0.28 | -0.27 | 23.49 | 2.81 | 14.21 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -4.34 | -3.95 | 22.68 | -7.87 | 17.33 | |||||
Accounts Receivable, 2 Yr. CAGR % | -3.58 | 1.1 | 23.63 | 14.7 | 1.86 | |||||
Inventory, 2 Yr. CAGR % | 26.2 | 19.9 | 17.14 | 20.69 | 2.51 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 68.71 | -3.92 | 3 | 1.27 | 7.37 | |||||
Total Assets, 2 Yr. CAGR % | 13.88 | 7.78 | 8.87 | 13.49 | 8.96 | |||||
Tangible Book Value, 2 Yr. CAGR % | 6.1 | -5.38 | -4.3 | 22.57 | 33.24 | |||||
Common Equity, 2 Yr. CAGR % | -11.23 | -10.62 | -23.6 | -15.59 | 12.46 | |||||
Cash From Operations, 2 Yr. CAGR % | 16.83 | 13.97 | 18.78 | 31.97 | 0.79 | |||||
Capital Expenditures, 2 Yr. CAGR % | 7.5 | 5.2 | 20.5 | 29.1 | 19.88 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 11.23 | 37.6 | 23.45 | 52.21 | -22.17 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 11.24 | 34.33 | 22.74 | 54.66 | -15.04 | |||||
Dividend Per Share, 2 Yr. CAGR % | -6.61 | 13.39 | 15.47 | 10.55 | 10 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 4.33 | 6.06 | 7.38 | 17.54 | 18.12 | |||||
Gross Profit, 3 Yr. CAGR % | 4.78 | 6.83 | 6.94 | 18.37 | 17.32 | |||||
EBITDA, 3 Yr. CAGR % | 5.1 | 7.08 | 6.27 | 8.61 | 17.66 | |||||
EBITA, 3 Yr. CAGR % | 5.43 | 7.28 | 6.52 | 6.61 | 18.02 | |||||
EBIT, 3 Yr. CAGR % | 4.32 | 6.38 | 6.03 | 9.73 | 16.93 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -1.34 | 6.37 | 6.42 | 5.01 | 16.69 | |||||
Net Income, 3 Yr. CAGR % | -0.42 | 7.21 | 7.35 | 3.91 | 17.44 | |||||
Normalized Net Income, 3 Yr. CAGR % | 5.04 | 7.48 | 6.7 | 9.69 | 16.79 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -1.66 | 3.93 | 4.21 | 1.36 | 19.09 | |||||
Accounts Receivable, 3 Yr. CAGR % | 1.25 | 4.16 | 8.72 | 16.95 | 9.26 | |||||
Inventory, 3 Yr. CAGR % | 21.46 | 19.43 | 22.62 | 15.93 | 10.46 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 47.63 | 44.22 | -2.43 | 2.63 | 5.08 | |||||
Total Assets, 3 Yr. CAGR % | 14.93 | 12.4 | 7.94 | 12.14 | 8.72 | |||||
Tangible Book Value, 3 Yr. CAGR % | 4.44 | 1.84 | -4.4 | 12.12 | 20.11 | |||||
Common Equity, 3 Yr. CAGR % | -6.55 | -15.17 | -15.57 | -17.97 | -1.6 | |||||
Cash From Operations, 3 Yr. CAGR % | 13.27 | 4.72 | 29.63 | 13.58 | 19.43 | |||||
Capital Expenditures, 3 Yr. CAGR % | 10.06 | 8.2 | 13.6 | 22.25 | 23.93 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -4.58 | 10.96 | 51.3 | 24.51 | 3.75 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -4.74 | 10.61 | 48.11 | 26.02 | 9.4 | |||||
Dividend Per Share, 3 Yr. CAGR % | -4.09 | 1.53 | 12.62 | 13.62 | 10.37 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 7.31 | 8.09 | 9.18 | 11.73 | 10.69 | |||||
Gross Profit, 5 Yr. CAGR % | 9.24 | 9.69 | 10.06 | 11.72 | 10.32 | |||||
EBITDA, 5 Yr. CAGR % | 9.62 | 11.24 | 10.6 | 5.85 | 10.17 | |||||
EBITA, 5 Yr. CAGR % | 10.06 | 11.69 | 11.03 | 4.7 | 10.41 | |||||
EBIT, 5 Yr. CAGR % | 8.61 | 11.03 | 10.71 | 5.68 | 9.45 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 7.89 | 12.3 | 8.53 | 1.56 | 9.51 | |||||
Net Income, 5 Yr. CAGR % | 6.1 | 11.7 | 9.88 | 1 | 10.2 | |||||
Normalized Net Income, 5 Yr. CAGR % | 5.48 | 10.59 | 12.06 | 5.59 | 9.64 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 5 | 9.1 | 7.44 | -0.96 | 9.28 | |||||
Accounts Receivable, 5 Yr. CAGR % | 12.37 | 8.41 | 9.67 | 8.26 | 5.92 | |||||
Inventory, 5 Yr. CAGR % | 17.75 | 13.9 | 19.71 | 19.93 | 14.14 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 31.95 | 32.64 | 27.83 | 25.21 | 1.38 | |||||
Total Assets, 5 Yr. CAGR % | 17.84 | 12.88 | 12.46 | 12.83 | 8.34 | |||||
Tangible Book Value, 5 Yr. CAGR % | 8.61 | 5.09 | 0.85 | 9.67 | 9.18 | |||||
Common Equity, 5 Yr. CAGR % | -3.29 | -4.98 | -13.78 | -15.34 | -5.31 | |||||
Cash From Operations, 5 Yr. CAGR % | 16.33 | 7.9 | 15.45 | 14.87 | 17.22 | |||||
Capital Expenditures, 5 Yr. CAGR % | 6.76 | 14.47 | 14.12 | 16.12 | 16.07 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 35.87 | 3.83 | 11.9 | 25.91 | 16.15 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 31.62 | 3.39 | 11.23 | 26.48 | 18.76 | |||||
Dividend Per Share, 5 Yr. CAGR % | -2.24 | 7.74 | 3.3 | 5.05 | 11.57 |
- Stock Market
- Equities
- EDEN Stock
- Financials Edenred SE
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















